Luigi Gargiulo

56PUBLICATIONS
138CO-AUTHORS
AllergyPharmaceutical sciencesEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Jul 25, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Jul 20, 2026
When Efficacy Meets Value: The Growing Case for IL-23 Inhibitors in Psoriasis.

|Jul 13, 2026
Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study.

|Jul 09, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study.

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

Pageof 10

Frequent Collaborators

26 joint publications

Luciano Ibba

22 joint publications

Antonio Costanzo

18 joint publications

Mario Valenti

11 joint publications

Angelo Valerio Marzano